SIGA Technologies (SIGA) Shares Tumble After Mpox Therapy Fails, Chief Medical Officer Terminated - Hagens Berman
SIGA Technologies Inc. (SIGA)
US:NASDAQ Investor Relations:
investor.siga.com/investor-relations
Company Research
Source: GlobeNewswire
SAN FRANCISCO, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Biopharmaceutical company SIGA Technologies is under intense scrutiny over its prior disclosures regarding the potential expansion of its lead product, TPOXX®, to treat Mpox. Hagens Berman encourages SIGA Technologies, Inc. (NASDAQ: SIGA) investors who suffered substantial losses to submit your losses now. The firm also encourages persons with knowledge who may assist the investigation to contact its attorneys. Visit: www.hbsslaw.com/investor-fraud/siga Contact the Firm Now: SIGA@hbsslaw.com 844-916-0895 Investigation Into SIGA Technologies, Inc. (SIGA): The inquiry centers on the company’s statements about the likelihood of securing FDA approval to broaden the drug’s label. In October 2022, SIGA initiated clinical trials to assess TPOXX®’s safety and efficacy for Mpox treatment in the Democratic Republic of Congo. SIGA’s CEO, Diem Nguyen, has consistently emphasized the urgent need for effec
Show less
Read more
Impact Snapshot
Event Time:
SIGA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SIGA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SIGA alerts
High impacting SIGA Technologies Inc. news events
Weekly update
A roundup of the hottest topics
SIGA
News
- Is Siga Technologies (SIGA) Stock Outpacing Its Medical Peers This Year? [Yahoo! Finance]Yahoo! Finance
- Interim Results from STOMP Study of SIGA's Tecovirimat in Treatment of Mpox Announced [Yahoo! Finance]Yahoo! Finance
- Interim Results from STOMP Study of SIGA’s Tecovirimat in Treatment of Mpox AnnouncedGlobeNewswire
- Siga Technologies (SIGA) Could Find a Support Soon, Here's Why You Should Buy the Stock Now [Yahoo! Finance]Yahoo! Finance
- SIGA Technologies Vs. Emergent BioSolutions: Product Portfolio And Future Outlook [Seeking Alpha]Seeking Alpha
SIGA
Sec Filings
- 12/13/24 - Form 8-K
- 12/10/24 - Form 8-K
- 11/8/24 - Form SC
- SIGA's page on the SEC website